Delphi Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.31M | Sell |
4,921
-741
| -13% | -$201K | 1.57% | 8 |
|
|
2025
Q4 | $1.42M | Buy |
5,662
+348
| +7% | +$92.4K | 1.38% | 45 |
|
|
2025
Q3 | $1.52M | Sell |
5,314
-161
| -3% | -$43.1K | 1.41% | 27 |
|
|
2025
Q2 | $1.44M | Sell |
5,475
-640
| -10% | -$156K | 1.39% | 23 |
|
|
2025
Q1 | $1.42M | Sell |
6,115
-360
| -6% | -$87.4K | 1.45% | 18 |
|
|
2024
Q4 | $1.49M | Sell |
6,475
-288
| -4% | -$66.1K | 1.44% | 29 |
|
|
2024
Q3 | $1.51M | Sell |
6,763
-1,483
| -18% | -$326K | 1.37% | 31 |
|
|
2024
Q2 | $1.68M | Buy |
8,246
+4,736
| +135% | +$963K | 1.37% | 37 |
|
|
2024
Q1 | $767K | Buy |
3,510
+410
| +13% | +$90.3K | 0.6% | 76 |
|
|
2023
Q4 | $705K | Buy |
+3,100
| New | +$651K | 0.65% | 70 |
|
|
2021
Q3 | – | Sell |
-6,305
| Closed | -$1.49M | – | 106 |
|
|
2021
Q2 | $1.49M | Buy |
6,305
+72
| +1% | +$16.4K | 1.43% | 5 |
|
|
2021
Q1 | $1.37M | Buy |
+6,233
| New | +$1.25M | 1.45% | 14 |
|
|
2019
Q3 | $1.42M | Sell |
9,822
-1,618
| -14% | -$236K | 1.38% | 25 |
|
|
2019
Q2 | $1.7M | Sell |
11,440
-293
| -2% | -$40.9K | 1.53% | 6 |
|
|
2019
Q1 | $1.54M | Sell |
11,733
-2,909
| -20% | -$358K | 1.43% | 24 |
|
|
2018
Q4 | $1.59M | Sell |
14,642
-652
| -4% | -$87.3K | 1.44% | 34 |
|
|
2018
Q3 | $2.28M | Sell |
15,294
-741
| -5% | -$113K | 1.47% | 14 |
|
|
2018
Q2 | $2.42M | Sell |
16,035
-519
| -3% | -$78.3K | 1.49% | 11 |
|
|
2018
Q1 | $2.3M | Sell |
16,554
-1,324
| -7% | -$194K | 1.4% | 27 |
|
|
2017
Q4 | $2.45M | Buy |
17,878
+69
| +0.4% | +$9.12K | 1.4% | 34 |
|
|
2017
Q3 | $2.31M | Sell |
17,809
-1,611
| -8% | -$215K | 1.29% | 41 |
|
|
2017
Q2 | $2.57M | Sell |
19,420
-422
| -2% | -$51.7K | 1.43% | 14 |
|
|
2017
Q1 | $2.45M | Sell |
19,842
-34
| -0.2% | -$4.03K | 1.4% | 41 |
|
|
2016
Q4 | $2.19M | Sell |
19,876
-467
| -2% | -$51.9K | 1.28% | 38 |
|
|
2016
Q3 | $2.4M | Sell |
20,343
-2,382
| -10% | -$281K | 1.5% | 11 |
|
|
2016
Q2 | $2.54M | Sell |
22,725
-992
| -4% | -$107K | 1.63% | 7 |
|
|
2016
Q1 | $2.39M | Buy |
23,717
+1,006
| +4% | +$96.5K | 1.44% | 19 |
|
|
2015
Q4 | $2.41M | Sell |
22,711
-63,327
| -74% | -$6.53M | 1.55% | 13 |
|
|
2015
Q3 | $8.02M | Sell |
86,038
-7,095
| -8% | -$734K | 1.26% | 41 |
|
|
2015
Q2 | $9.7M | Buy |
93,133
+7,124
| +8% | +$742K | 1.3% | 28 |
|
|
2015
Q1 | $9.32M | Sell |
86,009
-186
| -0.2% | -$19.1K | 1.24% | 35 |
|
|
2014
Q4 | $7.99M | Buy |
86,195
+4,774
| +6% | +$422K | 1.12% | 53 |
|
|
2014
Q3 | $7.12M | Sell |
81,421
-10,642
| -12% | -$962K | 1.01% | 57 |
|
|
2014
Q2 | $8.1M | Sell |
92,063
-26,837
| -23% | -$2.32M | 1.18% | 49 |
|
|
2014
Q1 | $10M | Sell |
118,900
-206
| -0.2% | -$16.4K | 1.09% | 56 |
|
|
2013
Q4 | $9.35M | Buy |
119,106
+109,459
| +1,135% | +$9.34M | 1.02% | 61 |
|
|
2013
Q3 | $822K | Buy |
9,647
+8
| +0.1% | +$674 | 0.09% | 104 |
|
|
2013
Q2 | $829K | Buy |
+9,639
| New | +$800K | 0.1% | 106 |
|
Other funds holding LH
VCM
VPM
Delphi Management's LH Position: Q1 2026 in Review
Delphi Management reduced its Labcorp (LH) stake by 13% in Q1 2026, selling an estimated $201K and leaving 4,921 shares worth $1.31M. The position accounts for 1.57% of the portfolio, ranked #8.
Delphi Management first reported a position in LH in Q2 2013 and has held it in 38 quarters since. The position peaked at $10M in Q1 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Delphi Management held 4,921 shares of Labcorp worth $1.31M as of Q1 2026.
- Delphi Management sold 741 Labcorp shares in Q1 2026, an estimated $201K.
- Labcorp made up 1.57% of Delphi Management's portfolio in Q1 2026, its #8 holding.
- Delphi Management first reported a position in Labcorp in Q2 2013 and has held it in 38 quarters since.
- Delphi Management's Labcorp position peaked at $10M in Q1 2014.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Delphi Management's 13F filing for Q1 2026, filed 20 Apr 2026.